Compounds > procainamide
Page last updated: 2024-11-03

procainamide and Anemia, Hemolytic, Autoimmune

procainamide has been researched along with Anemia, Hemolytic, Autoimmune in 2 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Anemia, Hemolytic, Autoimmune: Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kleinman, S1
Nelson, R1
Smith, L1
Goldfinger, D1
Wautier, JL1
Rouger, P1

Reviews

1 review available for procainamide and Anemia, Hemolytic, Autoimmune

ArticleYear
[Drug-induced hemolytic anemia].
    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2001, Volume: 8, Issue:4

    Topics: Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents, Non-Steroidal; Antimetab

2001

Other Studies

1 other study available for procainamide and Anemia, Hemolytic, Autoimmune

ArticleYear
Positive direct antiglobulin tests and immune hemolytic anemia in patients receiving procainamide.
    The New England journal of medicine, 1984, Sep-27, Volume: 311, Issue:13

    Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Antinuclear; Coombs Test; Erythrocytes; Humans; Mal

1984